APA aipamena

Strand, V., Mease, P., Burmester, G. R., Nikaï, E., Coteur, G., van Vollenhoven, R., . . . Kavanaugh, A. (2009). Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: Results from the RAPID 1 randomized controlled trial. BioMed Central.

Chicago Style aipamena

Strand, Vibeke, Philip Mease, Gerd R. Burmester, Enkeleida Nikaï, Geoffroy Coteur, Ronald van Vollenhoven, Bernard Combe, Edward C. Keystone, and Arthur Kavanaugh. Rapid and Sustained Improvements in Health-related Quality of Life, Fatigue, and Other Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol Plus Methotrexate Over 1 Year: Results From the RAPID 1 Randomized Controlled Trial. BioMed Central, 2009.

MLA aipamena

Strand, Vibeke, et al. Rapid and Sustained Improvements in Health-related Quality of Life, Fatigue, and Other Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol Plus Methotrexate Over 1 Year: Results From the RAPID 1 Randomized Controlled Trial. BioMed Central, 2009.